These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17503979)

  • 1. A randomized, double-blind, placebo-controlled trial of modafinil for negative symptoms in schizophrenia.
    Pierre JM; Peloian JH; Wirshing DA; Wirshing WC; Marder SR
    J Clin Psychiatry; 2007 May; 68(5):705-10. PubMed ID: 17503979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: a randomized, double-blind, placebo-controlled study.
    Lohr JB; Liu L; Caligiuri MP; Kash TP; May TA; Murphy JD; Ancoli-Israel S
    Schizophr Res; 2013 Oct; 150(1):289-96. PubMed ID: 23938173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial.
    Freudenreich O; Henderson DC; Macklin EA; Evins AE; Fan X; Cather C; Walsh JP; Goff DC
    J Clin Psychiatry; 2009 Dec; 70(12):1674-80. PubMed ID: 19689921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications.
    Sevy S; Rosenthal MH; Alvir J; Meyer S; Visweswaraiah H; Gunduz-Bruce H; Schooler NR
    J Clin Psychiatry; 2005 Jul; 66(7):839-43. PubMed ID: 16013898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study.
    Kane JM; D'Souza DC; Patkar AA; Youakim JM; Tiller JM; Yang R; Keefe RS
    J Clin Psychiatry; 2010 Nov; 71(11):1475-81. PubMed ID: 20816042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation.
    Swanson JM; Greenhill LL; Lopez FA; Sedillo A; Earl CQ; Jiang JG; Biederman J
    J Clin Psychiatry; 2006 Jan; 67(1):137-47. PubMed ID: 16426100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intractability of Deficit Syndrome of Schizophrenia Against Adjunctive Modafinil.
    Shoja Shafti S; Akbari S
    J Clin Psychopharmacol; 2016 Feb; 36(1):45-9. PubMed ID: 26658259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: a randomized, double-blind, placebo-controlled trial.
    Bobo WV; Woodward ND; Sim MY; Jayathilake K; Meltzer HY
    Schizophr Res; 2011 Aug; 130(1-3):106-13. PubMed ID: 21641776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review.
    Saavedra-Velez C; Yusim A; Anbarasan D; Lindenmayer JP
    J Clin Psychiatry; 2009 Jan; 70(1):104-12. PubMed ID: 19026265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.
    Kane JM; Carson WH; Saha AR; McQuade RD; Ingenito GG; Zimbroff DL; Ali MW
    J Clin Psychiatry; 2002 Sep; 63(9):763-71. PubMed ID: 12363115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia.
    Arbabi M; Bagheri M; Rezaei F; Ahmadi-Abhari SA; Tabrizi M; Khalighi-Sigaroudi F; Akhondzadeh S
    Psychopharmacology (Berl); 2012 Apr; 220(3):591-8. PubMed ID: 21947320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
    J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
    Orlikowski D; Chevret S; Quera-Salva MA; Laforêt P; Lofaso F; Verschueren A; Pouget J; Eymard B; Annane D
    Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive armodafinil for negative symptoms in adults with schizophrenia: a double-blind, placebo-controlled study.
    Kane JM; Yang R; Youakim JM
    Schizophr Res; 2012 Mar; 135(1-3):116-22. PubMed ID: 22178084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
    Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
    Addington DE; Pantelis C; Dineen M; Benattia I; Romano SJ
    J Clin Psychiatry; 2004 Dec; 65(12):1624-33. PubMed ID: 15641867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study.
    Schwartz JR; Hirshkowitz M; Erman MK; Schmidt-Nowara W
    Chest; 2003 Dec; 124(6):2192-9. PubMed ID: 14665500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study.
    Biederman J; Swanson JM; Wigal SB; Boellner SW; Earl CQ; Lopez FA;
    J Clin Psychiatry; 2006 May; 67(5):727-35. PubMed ID: 16841622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.
    Fava M; Thase ME; DeBattista C
    J Clin Psychiatry; 2005 Jan; 66(1):85-93. PubMed ID: 15669893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.